Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Maurel

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
British Journal of Cancer|November 11, 2017
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancerJordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Cancer|April 25, 2023
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinomaLucía Trilla-Fuertes, Angelo Gámez-Pozo, Miguel Nogué, et al.
JAMA Surgery|July 12, 2023
Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS StudyYoelimar Guzmán, José Ríos, Jesús Paredes, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Cancer Medicine|June 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal TimeXabier Garcia-Albeniz, Julia Vila-Guilera, Manuel Zamparini, et al.
British Journal of Cancer|November 11, 2017
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancerJordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
Cancer|April 25, 2023
Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinomaLucía Trilla-Fuertes, Angelo Gámez-Pozo, Miguel Nogué, et al.
JAMA Surgery|July 12, 2023
Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS StudyYoelimar Guzmán, José Ríos, Jesús Paredes, et al.
Pageof 12